Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Current drug targets. Inflammation & allergy

• Publication date

  2004-08-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1568010043343615PMID 15379589
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Biologics for severe asthma: deciphering what is best for the patient

  2025cites this paper
• The function of antibodies

  2024cites this paper
• The combination of machine learning and untargeted metabolomics identifies the lipid metabolism -related gene CH25H as a potential biomarker in asthma

  2023cites this paper
• Les canaux calciques Cav1 comme cible thérapeutique dans l’asthme allergique

  2019cites this paper
• Asthma and anaphylaxis.

  2019cites this paper
• Evolution of the IgE and IgG repertoire to a comprehensive array of allergen molecules in the first decade of life

  2018cites this paper
• Intake of a fermented plant product attenuates allergic symptoms without changing systemic immune responses in a mouse model of Japanese cedar pollinosis

  2018cites this paper
• Personalized medicine with biologics for severe type 2 asthma: current status and future prospects

  2017cites this paper
• 8 Air Pollution and Domestic Animals

  2017cites this paper
• dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies

  2017cites this paper
• Asthma, Food Allergy, and How They Relate to Each Other

  2017cites this paper
• Identification and Characterization of a Novel IL-4 Receptor α Chain (IL-4Rα) Antagonist to Inhibit IL-4 Signalling

  2015cites this paper
• Omalizumab (Xolair) – Anti‐Immunoglobulin E Treatment in Allergic Diseases

  2014cites this paper
• dust in the horse Early onset airway obstruction in response to organic

  2013cites this paper
• Methods for revealing therapeutic targets in case of true acantholytic pemphigus

  2012cites this paper
• Asthma in Children and Adolescents: A Comprehensive Approach to Diagnosis and Management

  2011cites this paper
• Air Pollution and Domestic Animals

  2011cites this paper
• The Pediatric Asthmatic

  2011cites this paper
• Mast cells in atopic dermatitis.

  2009cites this paper
• Engineering tissue alternatives to animals: applying tissue engineering to basic research and safety testing.

  2009cites this paper
• Sociedad Argentina de Pediatría. Subcomisiones, Comités y Grupos de Trabajo

  2009cites this paper
• Severe asthma and the omalizumab option

  2008cites this paper
• Atopic dermatitis in 2008.

  2008cites this paper
• Reduced expression of nicotinic α subunits 3, 7, 9 and 10 in lesional and nonlesional atopic dermatitis skin but enhanced expression of α subunits 3 and 5 in mast cells

  2008cites this paper
• Clinical significance of serum IgE

  2007cites this paper
• Early onset airway obstruction in response to organic dust in the horse.

  2007cites this paper
• A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma

  2007cites this paper
• Structure-activity relationships of 4-senecioyloxymethyl-6,7- dimethoxycoumarin analogues as anti-allergic agents

  2007cites this paper
• Atopy: new targets and new therapies.

  2006cites this paper
• Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.

  2006cites this paper
• Treating Moderate-to-Severe Allergic Asthma with a Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab)

  2006cites this paper
• Effects of omalizumab and budesonide on markers of inflammation in human bronchial epithelial cells.

  2005cites this paper
• Antigen-specific targeting and elimination of EBV-transformed B cells by allergen toxins.

  2005cites this paper
• Derleme |Review

  year unknowncites this paper